earnings
confidence high
sentiment positive
materiality 0.75
Solventum Q2 GAAP EPS $0.51, adj EPS $1.56; raises full-year guidance
Solventum Corp
2024-Q2 EPS reported
$1.88
revenue$4,097,000,000
- Reported sales $2.081B (+0.2% YoY); organic sales +1.3%; MedSurg and HIS drove growth.
- GAAP operating margin 11.7%; adjusted operating margin 20.7%; adjusted EPS $1.56.
- Generated $355M cash from ops; free cash flow $297M.
- Raises full-year 2024 organic sales growth and adjusted EPS guidance.